全文获取类型
收费全文 | 151976篇 |
免费 | 11320篇 |
国内免费 | 5025篇 |
专业分类
耳鼻咽喉 | 1397篇 |
儿科学 | 5360篇 |
妇产科学 | 1920篇 |
基础医学 | 24382篇 |
口腔科学 | 2750篇 |
临床医学 | 11810篇 |
内科学 | 25309篇 |
皮肤病学 | 3636篇 |
神经病学 | 21872篇 |
特种医学 | 2772篇 |
外国民族医学 | 24篇 |
外科学 | 10258篇 |
综合类 | 17602篇 |
现状与发展 | 24篇 |
一般理论 | 4篇 |
预防医学 | 9211篇 |
眼科学 | 2105篇 |
药学 | 15766篇 |
25篇 | |
中国医学 | 4668篇 |
肿瘤学 | 7426篇 |
出版年
2024年 | 232篇 |
2023年 | 2057篇 |
2022年 | 3544篇 |
2021年 | 6659篇 |
2020年 | 5543篇 |
2019年 | 5875篇 |
2018年 | 5695篇 |
2017年 | 5505篇 |
2016年 | 5185篇 |
2015年 | 5499篇 |
2014年 | 9994篇 |
2013年 | 12294篇 |
2012年 | 9293篇 |
2011年 | 10058篇 |
2010年 | 7875篇 |
2009年 | 7562篇 |
2008年 | 7551篇 |
2007年 | 6942篇 |
2006年 | 6020篇 |
2005年 | 5515篇 |
2004年 | 4831篇 |
2003年 | 4142篇 |
2002年 | 3224篇 |
2001年 | 2753篇 |
2000年 | 2441篇 |
1999年 | 2127篇 |
1998年 | 1930篇 |
1997年 | 1817篇 |
1996年 | 1471篇 |
1995年 | 1166篇 |
1994年 | 1104篇 |
1993年 | 933篇 |
1992年 | 774篇 |
1991年 | 743篇 |
1990年 | 620篇 |
1989年 | 505篇 |
1988年 | 501篇 |
1987年 | 478篇 |
1986年 | 410篇 |
1985年 | 1066篇 |
1984年 | 1118篇 |
1983年 | 751篇 |
1982年 | 860篇 |
1981年 | 701篇 |
1980年 | 583篇 |
1979年 | 518篇 |
1978年 | 427篇 |
1977年 | 334篇 |
1976年 | 308篇 |
1975年 | 298篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
31.
32.
《Pediatric clinics of North America》2015,62(6):1463-1477
33.
34.
周蕾 《国际妇产科学杂志》2015,42(1):91-95
宫颈癌对妇女健康构成严重威胁,人乳头瘤病毒感染与宫颈病变及宫颈癌的发生密切相关。关于宫颈癌发生发展的机制仍在研究中。近年研究发现一种多功能核蛋白,即死亡结构域相关蛋白(death domain associated protein,Daxx),其与细胞内蛋白或病毒蛋白相互作用,参与调节细胞凋亡、转录调控、抗病毒等细胞活动,在不同途径中发挥不同的生理或病理作用。通过对Daxx功能及其作用机制的研究有助于进一步阐明宫颈癌发生发展的机制,有助于发现新的预防和治疗方法。综述Daxx的一般特性和研究现况及其在宫颈病变的研究进展。 相似文献
35.
AimsThe effect of Origanum majorana tea consumption on motor and non-motor symptoms was investigated in patients with idiopathic Parkinson's disease, measured by validated tools.MethodsSixty patients with idiopathic Parkinson's disease and under conventional medication were enrolled voluntarily in the study. All participants were randomized on double-blind to placebo or Origanum majorana. Clinical assessment with validated tools (UPDRSIII, NMSS, and BDI) was done before Origanum majorana or placebo consumption (Day 0) and at the end of the experiment (Day 30).ResultsThe treatment groups were similar at baseline on demographic and clinical variables. During the course of study, nine participants withdrew for reasons of noncompliance and inability to follow-up. Fifty-one participants completed the study. Upon completion of 30 days of treatment, Origanum majorana tea consumption did not decrease the UPDRSIII score ([UPDRSIII] D0 = 18.76 ± 8.58, D30 = 16.52 ± 7.96, p = 0.069) at the p value was 0.07. However, a statistically significant improvement was noted in NMSS and BDI scores (p < 0.0001 and p < 0.0001, respectively). Assessment of the UPDRSIII, NMSS and BDI scores of the patients did not reflect any improvement with placebo. No side effect was detected during the study.ConclusionThese findings show improvement of depressive and non-motor signs in patients with Parkinson's disease in the group that consumed Origanum majorana tea in combination with conventional therapy. Improvement of motor signs may need an extended treatment period. However, more research with a large number of participants and lasting longer than 1 month is needed to argue these findings. 相似文献
36.
37.
《Clinical neurophysiology》2020,131(7):1444-1452
ObjectiveTo investigate cognitive functions in non-demented patients with early-onset Parkinson's disease (PD), and to compare PARK2 gene mutation carriers and non-carriers by means of event-related brain potentials (ERPs).MethodsThe participants comprised patients with early-onset PD (EOPD) and healthy controls (HC). Patients with EOPD were divided into two groups as carriers of known pathogenic variants of PARK2 gene (EOPD-PC) and non-carriers of genes involved in familial PD (EOPD-NC). ERP data were collected during auditory oddball and visual continuous performance test (CPT).ResultsBoth EOPD groups (EOPD-PC and EOPD-NC) displayed reduced and delayed P3 in response to oddball target and CPT NoGo. CPT Go P3 was reduced in EOPD-NC but not in EOPD-PC. Oddball target N1 was reduced and P2 was enhanced in both EOPD-PC and EOPD-NC. In both cognitive tasks, RTs were prolonged and accuracy was lower in EOPD-PC and EOPD-NC.ConclusionsWe found several EOPD-related neurophysiologic changes, implying impairments in cognitive functions. Pairwise comparisons between EOPD-PC and EOPD-NC revealed no significant ERP marker.SignificanceIn this study, the confounding effect of normative aging was somewhat excluded compared with many previous studies. In contrast with the many oddball studies in non-demented PD, we clearly observed reduced and prolonged P3 in early-onset PD. Our NoGo P3 findings also contribute to the limited ERP research concerning response inhibition. 相似文献
38.
39.
40.